Intrinsic and Extrinsic Regulation of Innate Immune Receptors

Overview

Journal Yonsei Med J

Specialty General Medicine

Date 2011 Apr 14

PMID 21488180

Citations 53

Authors

Eunshil Jeong

Joo Young Lee

Affiliations

Soon will be listed here.

Abstract

Pattern recognition receptors (PRRs) in innate immune cells play a pivotal role in the first line of host defense system. PRRs recognize pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs) to initiate and regulate innate and adaptive immune responses. PRRs include Toll-like receptors (TLRs), RIG-I-like receptors (RLRs) and NOD-like receptors (NLRs), which have their own features in ligand recognition and cellular location. Activated PRRs deliver signals to adaptor molecules (MyD88, TRIF, MAL/TIRAP, TRAM, IPS-1) which act as important messengers to activate downstream kinases (IKK complex, MAPKs, TBK1, RIP-1) and transcription factors (NF-κB, AP-1, IRF3), which produce effecter molecules including cytokines, chemokines, inflammatory enzymes, and type I interferones. Since excessive PRR activation is closely linked to the development of chronic inflammatory diseases, the role of intrinsic and extrinsic regulators in the prevention of over- or unnecessary activation of PRRs has been widely studied. Intracellular regulators include MyD88s, SOCS1, TOLLIP, A20, and CYLD. Extrinsic regulators have also been identified with their molecular targets in PRR signaling pathways. TLR dimerization has been suggested as an inhibitory target for small molecules such as curcumin, cinnamaldehyde, and sulforaphane. TBK1 kinase can be a target for certain flavonoids such as EGCG, luteolin, quercetin, chrysin, and eriodictyol to regulate TRIF-dependent TLR pathways. This review focuses on the features of PRR signaling pathways and the therapeutic targets of intrinsic and extrinsic regulators in order to provide beneficial strategies for controlling the activity of PRRs and the related inflammatory diseases and immune disorders.

Citing Articles

DAMPs, PAMPs, NLRs, RIGs, CLRs and TLRs - Understanding the Alphabet Soup in the Context of Bone Biology.

Carroll K, Sawden M, Sharma S Curr Osteoporos Rep. 2025; 23(1):6.

PMID: 39808398 DOI: 10.1007/s11914-024-00900-3.

Effects of drinking water supplemented with essential oils and organic acids mixtures on growth performance and intestinal health of broilers challenged with necrotic enteritis.

Huang J, Xu T, Guo F, Bi R, Lu H, Li P Poult Sci. 2024; 104(2):104712.

PMID: 39721270 PMC: 11732541. DOI: 10.1016/j.psj.2024.104712.

The Intriguing Connection Between the Gut and Lung Microbiomes.

Druszczynska M, Sadowska B, Kulesza J, Gasienica-Gliwa N, Kulesza E, Fol M Pathogens. 2024; 13(11).

PMID: 39599558 PMC: 11597816. DOI: 10.3390/pathogens13111005.

Immunity and Coagulation in COVID-19.

Avdonin P, Blinova M, Serkova A, Komleva L, Avdonin P Int J Mol Sci. 2024; 25(20).

PMID: 39457048 PMC: 11508857. DOI: 10.3390/ijms252011267.

A Review on Role of Inflammation in Coronavirus Disease.

Lotfi A, Hajian P, Abbasi L, Gargari M, Fard N, Naderi D Endocr Metab Immune Disord Drug Targets. 2024; 24(13):1488-1505.

PMID: 38303532 DOI: 10.2174/0118715303265274231204075802.

References

McWhirter S, Fitzgerald K, Rosains J, Rowe D, Golenbock D, Maniatis T . IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A. 2003; 101(1):233-8. PMC: 314168. DOI: 10.1073/pnas.2237236100. View

Joung S, Park Z, Rani S, Takeuchi O, Akira S, Lee J . Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1. J Immunol. 2010; 186(1):499-507. DOI: 10.4049/jimmunol.0903534. View

Zhang D, Zhang G, Hayden M, Greenblatt M, Bussey C, Flavell R . A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004; 303(5663):1522-6. DOI: 10.1126/science.1094351. View

Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L . An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol. 2003; 4(7):702-7. DOI: 10.1038/ni945. View

Boone D, Turer E, Lee E, Ahmad R, Wheeler M, Tsui C . The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004; 5(10):1052-60. DOI: 10.1038/ni1110. View

Masters S, Dunne A, Subramanian S, Hull R, Tannahill G, Sharp F . Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol. 2010; 11(10):897-904. PMC: 3103663. DOI: 10.1038/ni.1935. View

Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer J . MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem. 1998; 273(20):12203-9. DOI: 10.1074/jbc.273.20.12203. View

Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M . RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol. 2004; 5(5):503-7. DOI: 10.1038/ni1061. View

Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H . Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003; 301(5633):640-3. DOI: 10.1126/science.1087262. View

10.

Kawai T, Akira S . Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007; 13(11):460-9. DOI: 10.1016/j.molmed.2007.09.002. View

11.

Krug A, French A, Barchet W, Fischer J, Dzionek A, Pingel J . TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity. 2004; 21(1):107-19. DOI: 10.1016/j.immuni.2004.06.007. View

12.

Lee J, Hwang D . The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol Cells. 2006; 21(2):174-85. View

13.

Youn H, Lee J, Saitoh S, Miyake K, Kang K, Choi Y . Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem Pharmacol. 2006; 72(7):850-9. DOI: 10.1016/j.bcp.2006.06.021. View

14.

Stewart C, Stuart L, Wilkinson K, van Gils J, Deng J, Halle A . CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2009; 11(2):155-61. PMC: 2809046. DOI: 10.1038/ni.1836. View

15.

Unterholzner L, Keating S, Baran M, Horan K, Jensen S, Sharma S . IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 2010; 11(11):997-1004. PMC: 3142795. DOI: 10.1038/ni.1932. View

16.

Wang T, Town T, Alexopoulou L, Anderson J, Fikrig E, Flavell R . Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med. 2004; 10(12):1366-73. DOI: 10.1038/nm1140. View

17.

Abbott D, Wilkins A, Asara J, Cantley L . The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol. 2004; 14(24):2217-27. DOI: 10.1016/j.cub.2004.12.032. View

18.

Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J . Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440(7081):237-41. DOI: 10.1038/nature04516. View

19.

Barton G, Medzhitov R . Toll-like receptor signaling pathways. Science. 2003; 300(5625):1524-5. DOI: 10.1126/science.1085536. View

20.

Chen Z . Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol. 2005; 7(8):758-65. PMC: 1551980. DOI: 10.1038/ncb0805-758. View